A phase II pilot evaluation of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations.

Viniotis AF, Jameson GS, Wertheim BC, Roe DJ, Mocan D, Pearse S, Sharma S, Gordon MS, Von Hoff DD, Borazanci EH

DOI: 10.21037/jgo-2026-0468
Published: 2026 Oct 30
Container: Journal of gastrointestinal oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/jgo-2026-0468,
  title = {A phase II pilot evaluation of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations.},
  author = {Viniotis AF and Jameson GS and Wertheim BC and Roe DJ and Mocan D and Pearse S and Sharma S and Gordon MS and Von Hoff DD and Borazanci EH},
  year = {2026},
  journal = {Journal of gastrointestinal oncology},
  doi = {10.21037/jgo-2026-0468},
  url = {https://doi.org/10.21037/jgo-2026-0468}
}

RIS

TY  - JOUR
TI  - A phase II pilot evaluation of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations.
AU  - Viniotis AF
AU  - Jameson GS
AU  - Wertheim BC
AU  - Roe DJ
AU  - Mocan D
AU  - Pearse S
AU  - Sharma S
AU  - Gordon MS
AU  - Von Hoff DD
AU  - Borazanci EH
PY  - 2026
JO  - Journal of gastrointestinal oncology
DO  - 10.21037/jgo-2026-0468
UR  - https://doi.org/10.21037/jgo-2026-0468
ER  -

APA

AF, V., GS, J., BC, W., DJ, R., D, M., S, P., S, S., MS, G., DD, V. H., & EH, B. (2026). A phase II pilot evaluation of lurbinectedin in patients with advanced gastrointestinal malignancies with DNA repair mutations.. Journal of gastrointestinal oncology. https://doi.org/10.21037/jgo-2026-0468

Source records

pubmed · retrieved 2026-11-10T11:47:34.914Z